Follow-up reviews of results from direct-to-consumer genetic tests show 40 percent of the actionable gene variations reported in the tests, including some indicating disease risk, were erroneous. . . . → Read More: High False-Positive Rate Found in Consumer Genetic Tests
|
|||||
 One comment - (Comments are closed)  Regulations  biomedical, cancer, FDA, genomics, life sciences, medical device Initial results from two late-stage clinical trials show an experimental pain drug with non-opioid ingredients reduces the use of opioid pain relievers following surgery, compared to a placebo and standard care. . . . → Read More: Trials Show Pain Drug Reduces Post-Surgery Opioid Use One comment - (Comments are closed) Regulations biomedical, chemistry, clinical trials, FDA, life sciences, pharmaceuticals, physical sciences A technology that detects dangerous bacteria in patients’ blood samples in less than an hour received a breakthrough medical device designation from the U.S. Food and Drug Administration. . . . → Read More: Quick Bacterial Blood Detection Gains Breakthrough Tag One comment - (Comments are closed) New products, Regulations biomedical, engineering, entrepreneurs, FDA, life sciences, medical device, nanotechnology The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer. . . . → Read More: FDA Clears Consumer Genetic Breast Cancer Risk Tests Comments are closed Regulations biomedical, cancer, engineering, FDA, genomics, life sciences, medical device, software Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs. . . . → Read More: Precision Cancer Drug Shown Effective in Adults, Children Comments are closed New products, Regulations biomedical, biotechnology, cancer, clinical trials, Europe, FDA, life sciences, pharmaceuticals A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year. . . . → Read More: Trial Shows Treatment Desensitizes Peanut Allergies Comments are closed Regulations biomedical, biotechnology, clinical trials, Europe, FDA, life sciences, pharmaceuticals Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, engineering, FDA, genomics, life sciences, medical device, pharmaceuticals, preclinical, stem cells, university The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion. . . . → Read More: Cancer Analytics Company Acquired in $1.9B Deal Comments are closed Finance biomedical, cancer, engineering, equity, FDA, genomics, investment, life sciences, medical device, merger, software The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury. . . . → Read More: FDA Clears First Blood Test for Concussions Comments are closed Regulations biomarkers, biomedical, clinical trials, DoD, FDA, life sciences, medical device A report by a biotechnology industry organization says development efforts and financing for new drugs to treat pain and addiction are falling behind the health and safety needs of society. . . . → Read More: Report – Industry Pain, Addiction Drug Efforts Flagging Comments are closed Business conditions, Finance biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, life sciences, pharmaceuticals, venture capital |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
